EW - Citi opens downside catalyst watch on Edwards ahead of Q3 earnings report
2023-10-02 15:46:04 ET
More on Edwards Lifesciences
- Edwards Lifesciences: Rising Dominance In Structural Heart Disease
- Edwards Lifesciences Corporation (EW) Q2 2023 Earnings Call Transcript
- Edwards Lifesciences said to be the target of EU antitrust raid last week
- Oppenheimer upgrades Edwards to outperform, citing TTVR opportunity
- Seeking Alpha’s Quant Rating on Edwards Lifesciences
For further details see:
Citi opens downside catalyst watch on Edwards ahead of Q3 earnings report